Loading…
Ensuring Equal Access to Treatments Act of 2015
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
66pct
28d open
vs 6,526 other HR bills in the 114th — cohort avg 56d
Ensuring Equal Access to Treatments Act of 2015 Amends title XVIII (Medicare) of the Social Security Act, with respect to the prospective payment system for hospital outpatient department (OPD) services, to direct the Secretary of Health and Human Services to create certain additional groups of covered OPD services that classify separately, from those that do not utilize such a drug, procedures that utilize a drug (other than contrast agents, diagnostic radiopharmaceutical, or anesthesia drugs) that both has a cost above the drug packaging threshold and functions as a supply when used in a diagnostic test or procedure.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (10)
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Congress.gov source codes: H11100, H11100-A
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2017 · third_quarter · Medicare/Medicaid
H.R.1838 - Ambulatory Surgical Center Quality and Access Act of 2017 H.R.1017/S.479 - Removing Barriers to Colorectal Cancer Screening Act of 2017 H.R.1178 - Ensuring Equal Access to Treatments Act of 2015 H.R.1628 - American Health Care Act of 2017 Reform of Medicare payments to ASCs Reform of Medicare regulations dealing with ASCs
Client expense: $179,319 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2017 · third_quarter · Medicare/Medicaid
H.R.1838 - Ambulatory Surgical Center Quality and Access Act of 2017 H.R.1017/S.479 - Removing Barriers to Colorectal Cancer Screening Act of 2017 H.R.1178 - Ensuring Equal Access to Treatments Act of 2015 H.R.1628 - American Health Care Act of 2017 Reform of Medicare payments to ASCs Reform of Medicare regulations dealing with ASCs
Client expense: $179,319 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2017 · second_quarter · Medicare/Medicaid
H.R.1838 - Ambulatory Surgical Center Quality and Access Act of 2017 H.R.1017/S.479 - Removing Barriers to Colorectal Cancer Screening Act of 2017 H.R.1178 - Ensuring Equal Access to Treatments Act of 2015 H.R.1628 - American Health Care Act of 2017 Reform of Medicare payments to ASCs Reform of Medicare regulations dealing with ASCs
Client expense: $257,953 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2017 · first_quarter · Medicare/Medicaid
H.R.1838 - Ambulatory Surgical Center Quality and Access Act of 2017 H.R.1017/S.479 - Removing Barriers to Colorectal Cancer Screening Act of 2017 H.R.1178 - Ensuring Equal Access to Treatments Act of 2015 H.R.1628 - American Health Care Act of 2017 Reform of Medicare payments to ASCs Reform of Medicare regulations dealing with ASCs
Client expense: $183,176 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2017 · first_quarter · Medicare/Medicaid
Medicaid; H.R. 1178 Ensuring Equal Access to Treatments Act of 2015, ophthalmology
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Health Issues
Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152). Issues related to CMS Outpatient Prospective Payment System (OPPS) rule. H.R. 1178, Ensuring Equal Access to Treatments Act of 2015. S.1466, Ensuring Equal Access to Treatments Act of 2015. Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517).
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Health Issues
Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152). Issues related to CMS Outpatient Prospective Payment System (OPPS) rule. H.R. 1178, Ensuring Equal Access to Treatments Act of 2015. S.1466, Ensuring Equal Access to Treatments Act of 2015. Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517).
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Medicare/Medicaid
H.R. 1178, S. 1466, Ensuring Equal Access to Treatments Act of 2015: Medicare packaged payment reform.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Medicare/Medicaid
Issues related to the implementation of health care reform (P.L.111-148, P.L.111-152); Issues related to the Medicare hospital outpatient issues (H.R.1178, S.1466); Developing an Innovative Strategy for Antimicrobial Resistance Microorganisms Act of 2015 (DISARM) (H.R.512); Medicare Program; Part B Drug Payment Model, Proposed rule, CMS-1670-P (March 11, 2016) - Provisions related to the Medicare Part B Drug Payment Model; H.R. 5122: To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models - Suspending the Part B Drug Payment Model; Medicare Part D rebates policy issues.
Client expense: $740,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Medicare/Medicaid
- CMMI Part B Drug Payment Demonstration Program - General reimbursement issues - H.R. 1178- Ensuring Equal Access to Treatments Act- all provisions
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Medicare/Medicaid
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Client expense: Not reported · Firm income: $27,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Medicare/Medicaid
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; reimbursement of outpatient medications
Client expense: Not reported · Firm income: $75,000
Government targets: HOUSE OF REPRESENTATIVES
2016 · fourth_quarter · Health Issues
Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152). Issues related to CMS Outpatient Prospective Payment System (OPPS) rule. H.R. 1178, Ensuring Equal Access to Treatments Act of 2015. S.1466, Ensuring Equal Access to Treatments Act of 2015. Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517). Issues related to drug pricing.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Health Issues
H.R. 1707, Access to Frontline Health Care Act, all sections H.R. 1741, Truth in Health Marketing Act, all sections H.R. 1190, Protecting Seniors Access to Medicare Act, all sections S. 141, Protecting Seniors Access to Medicare Act, all sections P.L. 111-192, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010, all sections related to physicians and vision P.L. 111-148 Affordable Care Act, modifications: 1. Reducing regulatory/costly burdens on medical practices - relief from regulatory penalties 2. Preserving patient access to office ancillary testing services 4. Independent Payment Advisory Board H.R. 1312, National Health Service Corps Improvement Act Meaningful Use/EHR program issues P.L. 113-54, Drug Quality & Security Act, all sections Protecting Access to Medicare Act (P.L. 113-93) ASC Quality Reporting Program Medicare Advantage plan network adequacy H.R. 270, FlexIT Act, all sections H.R. 3309, Flex IT 2 Act, all sections S. 2141, Trust IT Act 2016 Physician Schedule Rule, sections pertaining to fee cuts Drug Price Increases Medicare Part B Drug Demonstration Medicare Access and CHIP Reauthorization Act (PL114-10) S.2777, Contact Lens Consumer Health Protection Act H.R. 6, 21st Century Cures Proposed 2017 Physician Fee Schedule. Section pertaining to global surgery data collection proposal H.R. 1178, Ensuring Equal Access to Treatment Act
Client expense: $160,000 · Firm income: Not reported
2016 · fourth_quarter · Medicare/Medicaid
Advocated for Medicare packaged payment reform. Advocated for the Ensuring Equal Access to Treatments Act (H.R. 1178 / S. 1466), to protect patient access to lifesaving medical procedures and breakthrough eye surgery.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Medical/Disease Research/Clinical Labs
Advocated for Medicare packaged payment reform. Advocated for the Ensuring Equal Access to Treatments Act (H.R. 1178 / S. 1466), to protect patient access to lifesaving medical procedures and breakthrough eye surgery.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Medicare/Medicaid
H.R. 1178, S. 1466, Ensuring Equal Access to Treatments Act of 2015: Medicare packaged payment reform.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Medicare/Medicaid
Issues related to the implementation of health care reform (P.L.111-148, P.L.111-152); Issues related to the Medicare hospital outpatient issues (H.R.1178, S.1466); Developing an Innovative Strategy for Antimicrobial Resistance Microorganisms Act of 2015 (DISARM) (H.R.512); Medicare Program; Part B Drug Payment Model, Proposed rule, CMS-1670-P (March 11, 2016) - Provisions related to the Medicare Part B Drug Payment Model; H.R. 5122: To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models - Suspending the Part B Drug Payment Model; Medicare Part D rebates policy issues.
Client expense: $420,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Medicare/Medicaid
- CMMI Part B Drug Payment Demonstration Program - General reimbursement issues - H.R. 1178- Ensuring Equal Access to Treatments Act- all provisions
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Health Issues
Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152). Issues related to CMS Outpatient Prospective Payment System (OPPS) rule. H.R. 1178, Ensuring Equal Access to Treatments Act of 2015. S.1466, Ensuring Equal Access to Treatments Act of 2015. Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517).
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Medicare/Medicaid
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Medicare/Medicaid
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; reimbursement of outpatient medications
Client expense: Not reported · Firm income: $75,000
Government targets: HOUSE OF REPRESENTATIVES
2016 · third_quarter · Health Issues
HR.1178 and S.1466, Ensuring Equal Access to Treatments Act; HR 2739, Cancer Drug Coverage Parity Act of 2015; Issues related to P.L. 96-517, the Bayh-Dole Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Medicare/Medicaid
Advocated for Medicare packaged payment reform. Advocated for the Ensuring Equal Access to Treatments Act (H.R. 1178 / S. 1466), to protect patient access to lifesaving medical procedures and breakthrough eye surgery. Advocated for improvements to FDA approval process.
Client expense: Not reported · Firm income: $45,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Medical/Disease Research/Clinical Labs
Advocated for Medicare packaged payment reform. Advocated for the Ensuring Equal Access to Treatments Act (H.R. 1178 / S. 1466), to protect patient access to lifesaving medical procedures and breakthrough eye surgery. Advocated for improvements to FDA approval process.
Client expense: Not reported · Firm income: $45,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Medicare/Medicaid
H.R. 1178, S. 1466, Ensuring Equal Access to Treatments Act of 2015: Medicare packaged payment reform.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Medicare/Medicaid
General reimbursement issues H.R. 1178 - Ensuring Equal Access to Treatments Act - all provisions
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Medicare/Medicaid
Issues related to the implementation of health care reform (P.L.111-148, P.L.111-152); Issues related to the Medicare hospital outpatient issues (H.R.1178, S.1466); Developing an Innovative Strategy for Antimicrobial Resistance Microorganisms Act of 2015 (DISARM) (H.R.512)
Client expense: $680,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Health Issues
Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152). Issues related to CMS Outpatient Prospective Payment System (OPPS) rule. H.R. 1178, Ensuring Equal Access to Treatments Act of 2015. S.1466, Ensuring Equal Access to Treatments Act of 2015. Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517).
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Medicare/Medicaid
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Medicare/Medicaid
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; reimbursement of outpatient medications
Client expense: Not reported · Firm income: $75,000
Government targets: HOUSE OF REPRESENTATIVES
2016 · second_quarter · Health Issues
HR.1178 and S.1466, Ensuring Equal Access to Treatments Act; HR 2739, Cancer Drug Coverage Parity Act of 2015; Issues related to P.L. 96-517, the Bayh-Dole Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Medical/Disease Research/Clinical Labs
Advocated for Medicare packaged payment reform. Advocated for the Ensuring Equal Access to Treatments Act (H.R. 1178 / S. 1466), to protect patient access to lifesaving medical procedures and breakthrough eye surgery.
Client expense: Not reported · Firm income: $45,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Medicare/Medicaid
Advocated for Medicare packaged payment reform. Advocated for the Ensuring Equal Access to Treatments Act (H.R. 1178 / S. 1466), to protect patient access to lifesaving medical procedures and breakthrough eye surgery.
Client expense: Not reported · Firm income: $45,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Medicare/Medicaid
H.R. 1178, S. 1466, Ensuring Equal Access to Treatments Act of 2015: Medicare packaged payment reform.
Client expense: Not reported · Firm income: Not reported
2016 · first_quarter · Medicare/Medicaid
Issues related to the implementation of health care reform (P.L.111-148, P.L.111-152); Issues related to the Medicare hospital outpatient issues (H.R.1178, S.1466); Developing an Innovative Strategy for Antimicrobial Resistance Microorganisms Act of 2015 (DISARM) (H.R.512)
Client expense: $680,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · first_quarter · Medicare/Medicaid
General reimbursement issues H.R. 1178 - Ensuring Equal Access to Treatments Act - all provisions
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · first_quarter · Medicare/Medicaid
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · first_quarter · Medicare/Medicaid
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; reimbursement of outpatient medications
Client expense: Not reported · Firm income: $70,000
Government targets: HOUSE OF REPRESENTATIVES
2016 · first_quarter · Health Issues
Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152). Issues related to CMS Outpatient Prospective Payment System (OPPS) rule. H.R. 1178, Ensuring Equal Access to Treatments Act of 2015. S.1466, Ensuring Equal Access to Treatments Act of 2015. Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517).
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · first_quarter · Medical/Disease Research/Clinical Labs
Advocated for Medicare packaged payment reform. Advocated for the Ensuring Equal Access to Treatments Act (H.R. 1178 / S. 1466), to protect patient access to lifesaving medical procedures and breakthrough eye surgery.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · first_quarter · Medicare/Medicaid
Advocated for Medicare packaged payment reform. Advocated for the Ensuring Equal Access to Treatments Act (H.R. 1178 / S. 1466), to protect patient access to lifesaving medical procedures and breakthrough eye surgery.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · first_quarter · Health Issues
HR.1178 and S.1466, Ensuring Equal Access to Treatments Act; HR 2739, Cancer Drug Coverage Parity Act of 2015; Issues related to P.L. 96-517, the Bayh-Dole Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · third_quarter · Medicare/Medicaid
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · fourth_quarter · Medicare/Medicaid
General reimbursement issues H.R. 1178 - Ensuring Equal Access to Treatments Act - all provisions
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · fourth_quarter · Medicare/Medicaid
Issues related to the implementation of health care reform (P.L.111-148, P.L.111-152); Issues related to the Medicare hospital outpatient issues (H.R.1178, S.1466); Developing an Innovative Strategy for Antimicrobial Resistance Microorganisms Act of 2015 (DISARM) (H.R.512)
Client expense: $680,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · fourth_quarter · Health Issues
Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152). Issues related to CMS Outpatient Prospective Payment System (OPPS) rule. H.R. 1178, Ensuring Equal Access to Treatments Act of 2015. S.1466, Ensuring Equal Access to Treatments Act of 2015.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · fourth_quarter · Health Issues
HR.1178 and S.1466, Ensuring Equal Access to Treatments Act; HR 2739, Cancer Drug Coverage Parity Act of 2015
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · fourth_quarter · Medicare/Medicaid
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; reimbursement of outpatient medications
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · fourth_quarter · Medicare/Medicaid
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Republican |
| OH |
| Bill Pascrell, Jr. | Democratic | NJ |
| Billy Long | Republican | MO |
| Bonnie Watson Coleman | Democratic | NJ |
| Brett Guthrie | Republican | KY |
| Charles B. Rangel | Democratic | NY |
| Charles W. Boustany Jr. | Republican | LA |
| Chris Collins | Republican | NY |
| Danny K. Davis | Democratic | IL |
| Diane Black | Republican | TN |
| Doris O. Matsui | Democratic | CA |
| Erik Paulsen | Republican | MN |
| Gregg Harper | Republican | MS |
| John Lewis | Democratic | GA |
| Joseph Crowley | Democratic | NY |
| Joseph J. Heck | Republican | NV |
| Kenny Marchant | Republican | TX |
| Leonard Lance | Republican | NJ |
| Linda T. Sánchez | Democratic | CA |
| Lois Capps | Democratic | CA |
| Lynn Jenkins | Republican | KS |
| Mark Takai | Democratic | HI |
| Mark Takano | Democratic | CA |
| Markwayne Mullin | Republican | OK |
| Marsha Blackburn | Republican | TN |
| Mike Kelly | Republican | PA |
| Mike Pompeo | Republican | KS |
| Mimi Walters | Republican | CA |
| Patrick Meehan | Republican | PA |
| Paul Tonko | Democratic | NY |
| Pete Olson | Republican | TX |
| Peter J. Roskam | Republican | IL |
| Peter Welch | Democratic | VT |
| Renee L. Ellmers | Republican | NC |
| Richard E. Neal | Democratic | MA |
| Richard Hudson | Republican | NC |
| Robert J. Dold | Republican | IL |
| Ron Kind | Democratic | WI |
| Scott H. Peters | Democratic | CA |
| Ted Lieu | Democratic | CA |
| Todd Young | Republican | IN |
| Zoe Lofgren | Democratic | CA |
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE